Criterium Inc

We track 2 ClinicalTrials.gov studies led by Criterium Inc. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by Criterium Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by Criterium Inc

A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer

NCT05458674 · RECRUITING · Phase 2

Multicenter Open Label Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer

NCT04791384 · TERMINATED · Phase 2

Frequently Asked Questions

How many clinical trials does Criterium Inc sponsor?

Criterium Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Criterium Inc research?

Criterium Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Criterium Inc recruiting for clinical trials?

Yes, Criterium Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More